DOI QR코드

DOI QR Code

폐이식 후 발생한 소화기계 합병증

Gastrointestinal Complications after Lung Transplantation

  • 함석진 (연세대학교 의과대학 강남세브란스병원 흉부외과학교실) ;
  • 백효채 (연세대학교 의과대학 강남세브란스병원 흉부외과학교실) ;
  • 김지현 (연세대학교 의과대학 강남세브란스병원 내과학교실) ;
  • 이두연 (연세대학교 의과대학 강남세브란스병원 흉부외과학교실) ;
  • 김창완 (연세대학교 의과대학 강남세브란스병원 흉부외과학교실) ;
  • 김정환 (연세대학교 의과대학 강남세브란스병원 흉부외과학교실)
  • Haam, Seok-Jin (Department of Thoracic and Cardiovascular Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Paik, Hyo-Chae (Department of Thoracic and Cardiovascular Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Kim, Ji-Hyun (Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Lee, Doo-Yun (Department of Thoracic and Cardiovascular Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Kim, Chang-Wan (Department of Thoracic and Cardiovascular Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Kim, Jung-Hwan (Department of Thoracic and Cardiovascular Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine)
  • 투고 : 2009.11.10
  • 심사 : 2010.02.09
  • 발행 : 2010.06.05

초록

배경: 폐 이식 수술 후 관리가 급속하게 발전함에도 불구하고 이식 후 소화기계 합병증은 여전히 중요한 문제점으로 남아있다. 저자들은 폐 이식 후 발생한 소화기계 합병증과 그의 치료법에 대해 후향적으로 연구하였다. 대상 및 방법: 1996년 7월부터 2009년 3월까지 23명의 환자에서 시행한 25예의 폐 또는 심폐이식에 대한 의무 기록을 검토하였다. 소화기계 합병증은 폐 이식 후 발생한 소화기계 질환으로 정의 하였다. 30일내 사망한 8명의 환자는 연구에서 제외하였다. 결과: 추적 관찰 기간은 중앙값 6.9개월(범위: 2개월 부터 111개월)로 수술 사망을 제외한 17예 중 11예(64.7%)에서 23회의 소화기계 합병증이 발생하였다. 만성 위염이 17예 중 4예(23.5%)에서 발생하여 가장 많았고, 2주 이상의 심한 설사가 3예에서 발생하였다. 3예에서 위궤양이 있었고 이중 1명의 환자는 궤양으로 인한 위천공으로 위 봉합술을 시행 받았다. 또한, 이 환자는 복부 수술 후 2개월 만에 궤양이 재발하여 위 출혈이 발생하였다. Cytomegalovirus에 의한 위염과 식도염이 각각 2예와 1예 있으며 식도 궤양은 2예 있었다. 식도 협착은 2예가 있었는데 스텐트를 삽입하여 치료하였다. 그밖에 장폐쇄, 황달을 동반한 담석, 위막성 대장염(pseudomembranous colitis), 내시경하 점막 절제술로 치료한 조기 위암이 각각 1예씩 있었다. 결론: 폐 이식 후 발생하는 소화기계 합병증은 발병률이 비교적 높은 편이며 폐 이식 후 환자의 영양 상태를 악화시켜 이환율과 사망률을 높이는 결과를 가져올 수 있기 때문에 적극적인 검사를 통한 조기 진단과 치료가 필요하다.

Background: The postoperative management following lung transplantation has dramatically improved in the recent decade. However, some complications still remain as troublesome problems. We retrospectively reviewed the gastrointestinal complications and their management after lung transplantation. Material and Method: We performed a retrospective review of the medical records of 25 cases in 23 patients who underwent lung and heart-lung transplantations from July 1996 to March 2009. The definition of gastrointestinal complication was the gastrointestinal tract-related disease that occurred after lung transplantation. There were eight postoperative deaths (within postoperative 30 days) that were excluded from the analysis. Result: Twenty three gastrointestinal complications occurred in 11 (64.7%) of the 17 cases. The median follow-up period was 6.9 months (range: 2 months to 111 months), and chronic gastritis (23.5%, 4 of 17 cases) was the most common complication. Severe, prolonged (more than 2 weeks) diarrhea occurred in 3 cases. Three patients had gastric ulcer with one case requiring gastric primary closure for gastric ulcer perforation. This patient had gastric bleeding due to recurrent gastric ulcer 2 months after laparotomy. Cytomegalovirus gastritis and esophagitis occurred in 2 cases and 1 case, respectively, and esophageal ulcer occurred in 2 cases. There were esophageal strictures in 2 patients who underwent esophageal stent insertion. Other complications were one case each of ileus, early gastric cancer requiring endoscopic mucosal resection, gall bladder stone accompanied with jaundice, and pseudomembranous colitis. Conclusion: The incidence of gastrointestinal complication is relatively high in patients after they undergo lung transplantation. Since gastrointestinal complications can induce malnutrition, which might be related to considerable morbidity and mortality, close follow-up is necessary for the early detection and proper management of gastrointestinal complications.

키워드

참고문헌

  1. Lubetkin EI, Lipson DA, Palevsky HI, et al. GI complications after orthotopic lung transplantation. Am J Gastroenterol 1996;91:2382-90
  2. Gilljam M, Chaparro C, Tullis E, Chan C, Keshavjee S, Hutcheon M. GI complications after lung transplantation in patients with cystic fibrosis. Chest 2003;123:37-41 https://doi.org/10.1378/chest.123.1.37
  3. King BJ, Iyer H, Leidi AA, Carby MR. Gastroesophageal reflux in bronchiolitis obliterans syndrome: a new perspective. J Heart Lung Transplant 2009;28:870-5 https://doi.org/10.1016/j.healun.2009.05.040
  4. Smith PC, Slaughter MS, Petty MG, Shumway SJ, Kshettry VR, Bolman RM 3rd. Abdominal complications after lung transplantation. J Heart Lung Transplant 1995;14:44-51
  5. Hoekstra HJ, Hawkins K, de Boer WJ, Rottier K, van der Bij W. Gastrointestinal complications in lung transplant survivors that require surgical intervention. Br J Surg 2001;88:433-8 https://doi.org/10.1046/j.1365-2168.2001.01693.x
  6. Paul S, Escareno CE, Clancy K, Jaklitsch MT, Bueno R, Lautz DB. Gastrointestinal complications after lung transplantation. J Heart Lung Transplant 2009;28:475-9 https://doi.org/10.1016/j.healun.2009.02.011
  7. Niklasson A, Strid H, Simren M, Engstrom CP. Bjornsson E. Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease. Eur J Gastroenterol Hepatol 2008;20:335-41 https://doi.org/10.1097/MEG.0b013e3282f2d0ec
  8. Cholongitas E, Pipili C, Dasenaki M, Goudras S. Are upper gastrointestinal symptoms associated with exacerbations of COPD? Int J Clin Pract 2008;62:967 https://doi.org/10.1111/j.1742-1241.2008.01772.x
  9. Anile M, Venuta F, Diso D, et al. Malignancies following lung transplantation. Transplant Proc 2007;39:1983-4 https://doi.org/10.1016/j.transproceed.2007.05.036
  10. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. The registry of the international society for heart and lung transplantation: twenty-first official adult lung and heart-lung transplant report--2004. J Heart Lung Transplant 2004;23:804-15 https://doi.org/10.1016/j.healun.2004.05.013
  11. Jaksch P, Zweytick B, Kerschner H, et al. Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy. J Heart Lung Transplant 2009;28:670-5 https://doi.org/10.1016/j.healun.2009.03.012

피인용 문헌

  1. Current perspective of lung transplantation vol.59, pp.2, 2010, https://doi.org/10.5124/jkma.2016.59.2.119